Inventor · disambiguated record
Jan Tejbrant
Also filed as: TEJBRANT JAN
9 granted patents·3 pending applications·138 citations·filing 2000–2022
87Inventor score
Top patents by PatentIndex Score
12 records- 0195US6465467B1Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseasesBIOVITRUM AB·Filed 2000·Granted Oct 15, 2002·72 cites·12 claims
- 0292US7071180B2Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseasesBIOVITRUM AB·Filed 2004·Granted Jul 4, 2006·38 cites·46 claims
- 0382US7534794B2Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseasesBIOVITRUM AB·Filed 2002·Granted May 19, 2009·12 cites·65 claims
- 0478US6969710B2CompoundsBIOVITRUM AB·Filed 2002·Granted Nov 29, 2005·10 cites·17 claims
- 0576US7319097B2CompoundsBIOVITRUM AB·Filed 2005·Granted Jan 15, 2008·2 cites·16 claims
- 0670US7173035B2Arylsulfonamide compoundsBIOVITRUM AB·Filed 2002·Granted Feb 6, 2007·4 cites·31 claims
- 0755US7566715B2Substituted sulfonamide compounds useful for the prophylaxis and treatment of conditions relating to obesity, type II diabetes and/or disorders of the central nervous systemBIOVITRUM AB·Filed 2005·Granted Jul 28, 2009·0 cites·20 claims
- 0850US2010022590A1Novel compoundsBIOVITRUM AB PUBL·Filed 2009·Application pending·0 cites
- 0950US2025339415A1Disulfide compounds as medicamentsCYTACOAT AB·Filed 2022·Application pending·0 cites
- 1048US7718650B2Aryl sulfonamide compounds for treating obesityBIOVITRUM AB·Filed 2007·Granted May 18, 2010·0 cites·13 claims
- 1143US2015025250A1Cysteine protease inhibitorsMEDIVIR UK LTD·Filed 2014·Application pending·0 cites
- 1240US8859505B2Cysteine protease inhibitorsAYESA SUSANA·Filed 2011·Granted Oct 14, 2014·0 cites·22 claims
Join the waitlist — get patent alerts
Get an alert when Jan Tejbrant files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →